Neuropharmacology and behavior in planarians: Translations to mammals

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 147, Issue 4, 2008, Pages 399-408

  Buttarelli, Francesca R ^a   Pellicano, Clelia ^a   Pontieri, Francesco E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Behavior; Evolution; Neural transmission; Planarian

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ASPARTIC ACID; CANNABINOID; CATECHOLAMINE; CHLORDIAZEPOXIDE; COCAINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER RECEPTOR; OPIATE; SEROTONIN;

BEHAVIOR; CIRCADIAN RHYTHM; CONFOCAL LASER MICROSCOPY; DOPAMINERGIC NERVE CELL; DRUG EXPOSURE; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOCHEMISTRY; HYPERKINESIA; IMMUNOFLUORESCENCE; IMMUNOGOLD STAINING; IMMUNOREACTIVITY; LEARNING; MAMMAL; MEMORY; MOLECULAR INTERACTION; MOTOR ACTIVITY; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; TURBELLARIA;

ANIMALIA; INVERTEBRATA; MAMMALIA; PLANARIA; TURBELLARIA; VERTEBRATA;

EID: 41449098537     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2008.01.009     Document Type: Review

References (80)

1. Akerman C.J., and Cline H.T. Defining the roles of GABAergic signaling during neural circuit formation. Trends Neurosci. 30 (2007) 425-431
2. Alam M., and Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 136 (2002) 317-324
3. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria. Comp. Biochem. Physiol. C 74 (1983) 27-29
4. Bradbury M.J., Dement W.C., and Edgar D.M. Serotonin-containing fibers in the suprachiasmatic hypothalamus attenuate light-induced phase delays in mice. Brain Res. 768 (1997) 125-134
5. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Acetylcholine/dopamine interactions in planaria. Comp. Biochem. Physiol. C 125 (2000) 225-231
6. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism. Progr. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 65-68
7. Buttarelli F.R., Patacchioli F.R., Palladini G., Brunetti E., and Pontieri F.E. Neuropharmacology of the cannabinoid system: from basic science to clinical applications. Curr. Neuropharmacol. 2 (2004) 1-7
8. Cadoni C., Pisanu A., Solinas M., Acquas E., and Di Chiara G. Behavioural sensitization after repeated exposure to delta-9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158 (2001) 259-266
9. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological studies. Neuropsychobiology 1 (1975) 355-364
10. Caronti B., Margotta V., Merante A., Pontieri F.E., and Palladini G. Treatment with 6-hydroxydopamine in planaria (Dugesia gonocephala): morphological and behavioral study. Comp. Biochem. Physiol. C 123 (1999) 201-207
11. Cebrià F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., and Agata K. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech. Dev. 116 (2002) 199-204
12. De Petrocellis L., Melck J., Bisogno T., Milone A., and Di Marzo V. Finding of the endocannabinoid signaling system in hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92 (1999) 377-387
13. Di Chiara G., Acquas E., Tanda G., and Cadoni C. Drugs of abuse: biochemical surrogates of specific aspects of natural rewards?. Biochem. Soc. Symp. 59 (1993) 65-81
14. Di Chiara G., Tanda G., Bassareo V., Pontieri F.E., Acquas E., Fenu S., Cadoni C., and Carboni E. Drug addiction as a disorder of associative learning. Role of the nucleus accumbens shell/extended amygdala dopamine. Ann. NY Acad. Sci. 877 (1999) 461-485
15. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connections. Neuropharmacology 47 suppl. 1 (2004) 227-241
16. Dudley T.E., Di Nardo L.A., and Glass J.D. Endogenous regulation of serotonin release in the hamster suprachiasmatic nucleus. J. Neurosci. 18 (1998) 5045-5052
17. Ellman G., Courtney D.K., Andres Jr. V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
18. Eriksson K.S., and Panula P. Gamma-aminobutyric acid in the nervous system of a planarian. J. Comp. Neurol. 345 (1994) 528-536
19. Falck B., Hillarp N.A., Thieme G., and Torp A. Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10 (1962) 348-354
20. Fernandes M.C., Alvares E.P., Gama P., and Sileira M. Serotonin in the nervous system of the head region of the land planarian Bipalium kewense. Tissue Cell 35 (2003) 479-486
21. Finkelstein R., and Boncinelli E. From fly head to mammalian forebrain: the story of otd and Otx. Trends Genet. 10 (1994) 310-315
22. Franquinet R., and Martelly I. Effects of serotonin and catecholamines on RNA synthesis in planarians; in vitro and in vivo studies. Cell. Differ. 10 (1981) 201-209
23. Ganter P., and Jollès G. Méthode de fluorescence de Spriggs (1966), puor catécholamines. In: Ganter P., and Jollès G. (Eds). Histochimie Normale et Pathologique (1979), Gauthier-Villars, Paris 1618-1634
24. Glass J.D., Hauser U.E., Blank J.L., Selim M., and Rea M.A. Differential timing of amino acid and 5-HIAA rhythms in the suprachiasmatic hypothalamus. Am. J. Physiol. 265 (1993) R504-R511
25. Grimm J.W., Hope B.T., Wise R.A., and Shaham Y. Incubation of cocaine craving after withdrawal. Nature 412 (2001) 141-142
26. Hughes A.J., Daniel S.E., and Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology, 57 (2001) 1497-1499
27. Itoh M.T., and Igarashi J. Circadian rhythm of serotonin levels in planaria. NeuroReport 11 (1996) 473-476
28. Kitamura Y., Kakimura J., and Taniguchi T. Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model. Jpn. J. Pharmacol. 78 (1998) 23-29
29. Kitamura Y., Inden M., Sanada H., Takata K., Taniguchi T., Shimohama S., Orii H., Mochii M., Agata K., and Watanabe K. Inhibitory effects of antiparkinsonian drugs and caspase inhibitors in a parkinsonian flatworm model. J. Pharmacol. Sci. 92 (2003) 137-142
30. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 (1991) 299-302
31. Kusayama T., and Watanabe S. Reinforcing effects of methamphetamine in planarians. NeuroReport 11 (2000) 2511-2513
32. Ladurner P., Mair G.R., Reiter D., Salvenmoser W., and Rieger R.M. Serotonergic nervous system of two macrostomid species: recent or ancient divergence?. Invertebr. Biol. 116 (1997) 178-191
33. Lalonde R., and Strazielle C. Brain regions and genes affecting postural control. Prog. Neurobiol. 81 (2007) 45-60
34. Li M.H. Effects of nonionic and ionic surfactants on survival, oxidative stress, and cholinesterase activity of planarian. Chemosphere 70 (2008) 1796-1803
35. Marchant E.G., Watson N.V., and Mistlberger R.E. Both neuropeptide Y and serotonin are necessary for entrainment of circadian rhythms in mice by daily treadmill running schedules. J. Neurosci. 17 (1997) 7974-7987
36. Margotta V., Caronti B., Meco G., Merante A., Ruggieri S., Venturini G., and Palladini G. Effects of cocaine treatment on the nervous system of planaria (Dugesia gonocephala, s.l.). Histochemical and ultrastructural observations. Eur. J. Histochem. 41 (1997) 223-230
37. Mc Sweeney F.K., Murphy, and Kowal B.P. Regulation of drug taking by sensitization and habituation. Exp. Clin. Psychopharmacol. 13 (2005) 163-184
38. Meisenzahl E.M., Schmitt G.J., Scheuerecker J., and Moller H.J. The role of dopamine for the pathophysiology of schizophrenia. Int. Rev. Psychiatry 19 (2007) 337-345
39. Nakazawa M., Cebrià F., Mineta K., Ikeo K., Agata K., and Gojobori T. Search for the evolutionary origin of a brain: planarian brain characterized by microarray. Mol. Biol. Evol. 20 (2003) 784-791
40. Ness D.K., Foley G.L., Villar D., and Hansen L.H. Effects of 3-iodo-l-tyrosine, a tyrosine hydroxylase inhibitor, on eye pigmentation and biogenic amines in the planarian, Dugesia dorotocephala. Fundament. Appl. Toxicol. 30 (1996) 153-161
41. Nishimura K., Kitamura Y., Inoue T., Umesono Y., Yoshimoto K., Takeuchi K., Taniguchi T., and Agata K. Identification and distribution of tryptophan hydroxylase (TPH)-positive neurons in the planarian Dugesia japonica. Neurosci. Res. 59 (2007) 101-106
42. O'Neil M.J., and Dix S. AMPA receptor potentiators as cognitive enhancers. Drugs 10 (2007) 185-192
43. Palladini G., Margotta V., Carolei A., and Hernandez M.C. Dopamine agonist performance in planaria after manganese treatment. Experientia 36 (1980) 449-450
44. Palladini G., Margotta V., Carolei A., Chiarini F., Del Piano M., Lauro G.M., Medolago Albani L., and Venturini G. The cerebrum of Dugesia gonocephala s.l. Platyhelmintes, Turbelleria, Triciclada. Morphological and functional observations. J. Hirnforsch. 24 (1983) 165-172
45. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol. C 115 (1996) 41-45
46. Palucha A., and Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol. Ther. 115 (2007) 116-147
47. Passarelli F., Merante A., Pontieri F.E., Margotta V., Venturini G., and Palladini G. Opioid-dopamine interactions in planaria: a behavioral study. Comp. Biochem. Physiol. C 124 (1999) 51-55
48. Pisani A., Bonsi P., Centonze D., Gubellini P., Bernardi G., and Calabresi P. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors. Neuropharmacology 45 (2003) 45-56
49. Pontieri F.E., Monnazzi P., Scontrini A., Buttarelli F.R., and Patacchioli F.R. Behavioral sensitization to WIN55212.2 in rats pretreated with heroin. Brain Res. 898 (2001) 178-180
50. Pontieri F.E., Monnazzi P., Scontrini A., Buttarelli F.R., and Patacchioli F.R. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. Eur. J. Pharmacol. 421 (2001) R1-R3
51. Raffa R.B., Valdez J.M., Holland L.J., and Schulingkamp R.J. Energy-dependent UV light-induced disruption of (-)sulpiride antagonism of dopamine. Eur. J. Pharmacol. 406 (2000) R11-R12
52. Raffa R.B., and Valdez J.M. Cocaine withdrawal in planaria. Eur. J. Pharmacol. 430 (2001) 143-145
53. Raffa R.B., Stagliano G.W., and Umeda S. κ-Opioid withdrawal in planaria. Neurosci. Lett. 349 (2003) 139-142
54. Raffa R.B., and Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by block by UV. Brain Res. 1031 (2005) 138-140
55. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in planaria. Brain Res. 1032 (2005) 200-202
56. Raffa R.B., Baron D.A., and Tallarida R.J. Schild (apparent pA2) analysis of a κ-opioid antagonist in planaria. Eur. J. Pharmacol. 540 (2006) 200-201
57. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subaddictive withdrawal from cocaine/κ-opioid agonist combinations in planaria. Brain Res. 1114 (2006) 31-35
58. Raffa R.B., Cavallo F., and Capasso A. Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur. J. Pharmacol. 564 (2007) 88-93
59. Raffa R.B., Stagliano G.W., and Tallarida R.J. Nonlinear isobologram and superaddictive withdrawal from cocaine:cannabinoid combinations in planarians. Eur. J. Pharmacol. 556 (2007) 89-90
60. Rawls S.M., Gomez T., Stagliano G.W., and Raffa R.B. Measurement of glutamate and aspartate in planaria. J. Pharmacol. Toxicol. Meth. 53 (2006) 291-295
61. Rawls S.M., Rodriguez T., Baron D.A., and Raffa R.B. A nitric oxide synthase inhibitor (l-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in planaria. Brain Res. 1099 (2006) 82-87
62. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol. Biochem. Behav. 86 (2007) 499-504
63. Reuter M., Maule A.G., Halton D.W., Gustafsson M.K.S., and Shaw C. The organization of the nervous system in Plathelminthes. The neuropeptide F-immunoreactive pattern in Catenulida, Macrostomida, Proseriata. Zoomorphology 115 (1985) 83-97
64. Sánchez-Alvarado A. Planarian regeneration: its end is its beginning. Cell 124 (2006) 241-245
65. Saitoh O., Yuruzume E., and Nakata H. Identification of planarian serotonin receptor by ligand binding and PCR studies. NeuroReport 8 (1996) 173-178
66. Saitoh O., Yuruzume E., Watanabe K., and Nakata H. Molecular identification of a G protein-coupled receptor family which is expressed in planarians. Gene 195 (1997) 55-61
67. Sarnat H.B., and Netsky M.G. Evolution of the nervous system. 2nd ed (1982), Oxford University Press, New York, NY
68. Sarnat H.B., and Netsky M.G. When does a ganglion become a brain? Evolutionary origin of the central nervous system. Semin. Pediatr. Neurol. 9 (2002) 240-253
69. Swanson L.W. What is the brain?. Trends Neurosci. 23 (2000) 519-527
70. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu-1 opioid receptor mechanism. Science 276 (1997) 2048-2050
71. Tanda G., and Di Chiara G. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur. J. Neurosci. 10 (1998) 1179-1187
72. Towey K.C., Oldham K.G., and Whelan J.A.M. A simple direct assay for cyclic AMP in plasma and other biological samples used an improved competitive protein binding technique. Clin. Chim. Acta 56 (1974) 221-234
73. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12 (2007) 227-462
74. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and κ-opioid withdrawal in planaria blocked by d-, but not l-, glucose. Brain Res. 1018 (2004) 181-185
75. Umeda S., Stagliano G.W., Borenstein M.R., and Raffa R.B. A reverse-phase HPLC and fluorescence detection method for the measurement of 5-hydroxytryptamine (serotonin) in planaria. J. Pharmacol. Toxicol. Meth. 51 (2005) 73-76
76. Venturini G., Carolei A., Palladini G., Margotta V., and Lauro G.M. Radioimmunological and immunocytochemical demonstration of Met-enkephalin in planaria. Comp. Biochem. Physiol. C 74 (1983) 23-25
77. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 28 (1989) 1377-1382
78. Webb R.A., and Eklove H. Demonstration of intense glutamate-like immunoreactivity in the longitudinal nerve cords of the cestode Hymenolepis diminuta. Parasitol. Res. 75 (1989) 545-548
79. Welsh J., and Williams L.D. Monoamine-containing neurons neurons in planaria. J. Comp. Neurol. 138 (1970) 103-116
80. Wickens J.R., Horvitz J.C., Costa R.M., and Killcross S. Dopaminergic mechanisms in actions and habits. J. Neurosci. 27 (2007) 8181-8183